BRG Board Approves Appointment of David Teece as Executive Chairman and Tri MacDonald as Principal Executive Officer

BRG further strengthens corporate governance and leadership team for the second decade of continued growth.

BRG announced today that the its Board of Managers has unanimously approved the appointment of Dr. David J. Teece as executive chairman and Tri MacDonald as principal executive officer. These appointments align governance and leadership for continued growth and will be effective as of January 1, 2021.

Dr. Teece, who cofounded BRG in 2010, served previously as chairman and principal executive officer. In his role as executive chairman, he will continue to lead the Board of Managers and will be primarily responsible for BRG’s longer-term strategy, new initiatives and thought leadership, including through the Berkeley Research Group Institute (BRGI).

Mr. MacDonald, a senior member of the BRG Health Analytics practice, previously held the role of president. In his new role as principal executive officer and president, he will report to the Board of Managers through the executive chairman and have primary authority and responsibility for BRG’s operational management, including service-line leadership relationships.

Commenting on his appointment, Dr. Teece said, “For over a decade, BRG has grown from strength to strength, with some of the smartest minds, practitioners and advisors delivering for our clients. I’m proud of what we have built and proud to take on this executive role as we align ourselves for the next chapter of our growth story. My congratulations to Tri as we formalize the roles he and I have been performing for some time.”

“I’m humbled to work with the great team at BRG and to take this step as we evolve our leadership roles and responsibilities, and align our governance,” Mr. MacDonald said. “I look forward to continuing to work with all of my colleagues to drive growth and deliver world-class service for our clients.”